Category Archives: Protein Engineering

The “AI-ntibody” Competition: benchmarking in silico antibody screening/design

We recently contributed to a communication in Nature Biotechnology detailing an upcoming competition coordinated by Specifica to evaluate the relative performance of in vitro display and in silico methods at identifying target-specific antibody binders and performing downstream antibody candidate optimisation.

Following in the footsteps of tournaments such as the Critical Assessment of Structure Prediction (CASP), which have led to substantial breakthroughs in computational methods for biomolecular structure prediction, the AI-ntibody initiative seeks to establish a periodic benchmarking exercise for in silico antibody discovery/design methods. It should help to identify the most significant breakthroughs in the space and orient future methods’ development.

Continue reading

Protein Property Prediction Using Graph Neural Networks

Proteins are fundamental biological molecules whose structure and interactions underpin a wide array of biological functions. To better understand and predict protein properties, scientists leverage graph neural networks (GNNs), which are particularly well-suited for modeling the complex relationships between protein structure and sequence. This post will explore how GNNs provide a natural representation of proteins, the incorporation of protein language models (PLLMs) like ESM, and the use of techniques like residual layers to improve training efficiency.

Why Graph Neural Networks are Ideal for Representing Proteins

Graph Neural Networks (GNNs) have emerged as a promising framework to fuse primary and secondary structure representation of proteins. GNNs are uniquely suited to represent proteins by modeling atoms or residues as nodes and their spatial connections as edges. Moreover, GNNs operate hierarchically, propagating information through the graph in multiple layers and learning representations of the protein at different levels of granularity. In the context of protein property prediction, this hierarchical learning can reveal important structural motifs, local interactions, and global patterns that contribute to biochemical properties.

Continue reading

The wider applications of nanobodies

This week, it was my turn to give the short talk at our group meeting. I chose to present a recently published paper on thermostability prediction for nanobodies. The motivation for this work, at least in part, is the need for thermostability in the diverse applications of nanobodies. At OPIG, our research primarily revolves around the therapeutic uses of nanobodies, but their potential extends beyond this. I thought it would be interesting to highlight some of these broader applications here:

Continue reading

Conference Summary: MGMS Adaptive Immune Receptors Meeting 2024

On 5th April 2024, over 60 researchers braved the train strikes and gusty weather to gather at Lady Margaret Hall in Oxford and engage in a day full of scientific talks, posters and discussions on the topic of adaptive immune receptor (AIR) analysis!

Continue reading

What can you do with the OPIG Immunoinformatics Suite? v3.0

OPIG’s growing immunoinformatics team continues to develop and openly distribute a wide variety of databases and software packages for antibody/nanobody/T-cell receptor analysis. Below is a summary of all the latest updates (follows on from v1.0 and v2.0).

Continue reading

The State of Computational Protein Design

Last month, I had the privilege to attend the Keystone Symposium on Computational Design and Modeling of Biomolecules in beautiful Banff, Canada. This conference gave an incredible insight into the current state of the protein design field, as we are on the precipice of advances catalyzed by deep learning.

Here are my key takeaways from the conference:

Continue reading

Experience at a Keystone Symposium

From 19th-22nd February I was fortunate enough to participate in the joint Keystone Symposium on Next-Generation Antibody Therapeutics and Multispecific Immune Cell Engagers, held in Banff, Canada. Now in their 51st year, the Keystone Symposia are a comprehensive programme of scientific conferences spanning the full range of topics relating to human health, from studies on fundamental bodily processes through to drug discovery.

Continue reading

3 Key Questions to Think About When Designing Proteins Computationally

We have reached the era of design, not just ‘hunting’. Particularly exciting to me is the de novo design of proteins, which have a wide and ever increasing range of applications from therapeutics to consumer products, biomanufacturing to biomaterials. Protein design has been a) enabled by decades of research that contributed to our understanding of protein sequence, structure & function and b) accelerated by computational advances – capturing the information we have learned from proteins and representing it for computers and machine learning algorithms.

In this blog post, I will discuss three key methodological considerations for computational protein design:

  1. Sequence- vs structure-based design
  2. ML- vs physics-based design
  3. Target-agnostic vs target-aware design
Continue reading

A quantitative way to measure targeted protein degradation

Whenever we order consumables in the Chemistry department, the whole lab gets an email notification once they arrive. So I can understand why I got some puzzled reactions from my colleagues when one such email arrived saying that my ‘artichoke’ was ready to collect from stores. Had I been sneakily doing my grocery shopping on a university research budget?

Artichoke is, in fact, the name of a plasmid designed by the Ebert lab (https://www.addgene.org/73320/), which I have been using in some of my research on targeted protein degradation. The premise is simple enough: genes for two different fluorescent proteins, one of which is fused to a protein-of-interest.

Continue reading

What is a plantibody?

Plants can be genetically engineered to express non-native proteins, for example, crops can be engineered to produce insect toxins in order to improve disease-resistance. However, I was not aware of their ability to express antibodies until, inspired by my expanding collection of house plants, I googled ‘plant immune systems’. 

Plants don’t naturally produce antibodies – they do not possess an adaptive immune system or any circulating immune defence cells. Despite this, plants can be made to express and assemble full length antibody heavy chains and light chains. This was first published back in 1989, when Hiatt et al. [1] successfully introduced mouse immunoglobulin genes to tobacco plants and produced functional antibodies with reasonable efficiency. The excellent term ‘plantibody‘ was coined soon after, to refer to antibodies and fragments of antibodies produced by plants transformed with antibody-coding genes. 

Continue reading